NCT02902666View on ClinicalTrials.gov

Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Healthy

Interventions

DRUG

Paracetamol 1000 mg/codeine phosphate hemihydrate 30 mg tablet

DRUG

Paracetamol 500 mg/codeine phosphate hemihydrate 30 mg tablet

Sponsors

Collaborators (1)

Cross Research S.A.

All Listed Sponsors

collaborator

Cross Research S.A.

INDUSTRY

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY

NCT02902666 - Bioequivalence Study of One Tablet of Paracetamol 1000 mg + Codeine 30 mg vs. Two Tablets of Paracetamol 500 mg + Codeine 30 mg | Biotech Hunter | Biotech Hunter